Resistance of ER-positive breast cancer to tamoxifen therapy may be driven by APOBEC3 [Archive]

View Full Version : Resistance of ER-positive breast cancer to tamoxifen therapy may be driven by APOBEC3

News

12-10-2015, 10:30 AM

Responses to tamoxifen were significantly prolonged by reducing levels of the enzyme APOBEC3B in preclinical models of estrogen receptor-positive breast cancer and significantly shortened by...

More... (http://www.medicalnewstoday.com/releases/303934.php)